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Primary tumors of the heart are rare.1,2 CPFs, the second most
common primary cardiac tumors, are benign endocardial papillo-
mas predominantly affecting the cardiac valves.3 Although CPFs
occur in all age groups, ranging from the neonatal period to the
10th decade of life, they clearly predominate in adults and are
particularly frequent between the fourth and eighth decades of
life. CPFs are more common in male subjects in most case
series. They are generally slow-growing tumors but might serve
as a nidus, allowing formation of large superimposed thrombi
over a short period of time and therefore might result in
life-threatening complications.4 Although the CPF is a morpho-
logically distinctive cardiac lesion, its histogenesis remains
controversial.
Clinical Summary
A 35-year-old man was admitted with acute pulmonary edema. He
had a 3-month history of progressive dyspnea under ordinary
exertion accompanied by chest pain. The patient was severely ill at
presentation, with orthopnea and cold sweats. Respirations were
27 breaths/min, and fine inspiratory crackles were audible across
the whole chest. The patient had sinus tachycardia, and a previ-
ously unknown 4/6 systolic murmur was audible in the aortic
position. This murmur was transmitted into the carotid arteries and
was accompanied by a diastolic murmur and a muted second heart
sound. Hematologic, coagulatory, and fibrinolytic tests showed no
abnormalities. The C-reactive protein level (1.8 mg/dL) was
slightly above normal range.
Transthoracic and transesophageal echocardiography revealed
a slightly impaired left ventricular function. The aortic valve
showed pronounced echocardiography-dense thickened leaflets,
merging into the left ventricular outflow tract (LVOT) and toward
the basis of the anterior mitral leaflet (Figure 1). Morphologically,
almost no opening movement was detectable, and the assessed
aortic valve opening area was 0.75 cm2, with a gradient of 110/70
mm Hg and a severe aortic valve regurgitation. In transition of the
anterior left ventricular wall to the LVOT, a 3  3–mm mobile
structure was evident (Figure 2, A). In the immediate vicinity an
additional mobile structure was present on a thickened chorda
tendinea, ranging from the anterolateral papillary muscle to the
central and anterolateral anterior mitral leaflet. In the middle of
both papillary muscles, aberrant chordae tendinea was present
between the 2 muscles, with another mobile structure between the
anterolateral papillary muscle and the anterolateral ventricular wall
(Figure 2, B).
Cardiac surgery revealed a morphologically inconspicuous mi-
tral valve. Inspection of the subvalvular region and the left ven-
tricle revealed multiple gelatin-like tumors distributed all over the
heart, including the chordae tendineae. The aortic valve leaflets
were impossible to differentiate, resulting in an almost monocus-
pid aortic valve. Resection of the aortic valve was complicated by
an excessive calcification, which included the LVOT and the
intraventricular septum. Multiple gelatin-like tumors were spotted
toward the aortic valve in the LVOT and the mitral valve appara-
tus. A curative excision of the tumor appeared to be impossible
because of its extensive spreading. Therefore 2 masses were re-
sected from the LVOT and the anterior papillary muscle/chordae
tendineae for histologic examination. Microscopy revealed a pap-
illary tumor with a central core of collagen and elastic fibers beside
small-lesion calcifications and villus fronds covered by an endo-
thelial layer without any cellular atypia found within the mass,
which is consistent with the diagnosis of cardiac papillary fibro-
elastoma (CPF). Histologic examination of the excised aortic valve
revealed a degenerative sclerosis of the valve consistent with a
prior endocarditis.
The patient had an uneventful postoperative course and was
discharged after adequate oral anticoagulation with phenprocoumon.
One-year follow-up transesophageal echocardiography showed good
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doi:10.1016/j.jtcvs.2006.09.051 Figure 1. Transesophageal 3-chamber view. LA, Left atrium; AML,
anterior mitral leaflet; AV, aortic valve; LV, left ventricle.
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function of the aortic valve and no further growth or additional
tumor growth after cardiac surgery.
Discussion
This case describes a patient with the unusual finding of mul-
tiple cardiac fibroelastomas involving the mitral valve and the
LVOT in addition to an altered aortic valve after prior valve
endocarditis. We hypothesize that the local accumulation of
mobile structures might be, at least in part, because of the
congenital altered bicuspid aortic valve and consecutive inflam-
matory alteration. Furthermore, accelerated by aortic regurgi-
tations, jet lesions in the subvalvular region of the mitral valve
and the adjacent left ventricle might have contributed to the
development of the tumor. After surgical replacement of the
formerly infected aortic valve, tumor growth appeared to dis-
continue.
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Facile conversion from mechanical to
bioprosthetic composite aortic root replacement
Luca A. Vricella, MD, and Duke E. Cameron, MD, Baltimore, Md
Aortic root replacement with a composite valve graftmechanical prosthesis has become established therapyfor acute and chronic pathology that eventually leads toenlargement, dissection, or rupture of the aortic root.
Although minimal early and late morbidity and mortality have been
reported, some patients
will require operative
reintervention on the
neoaortic root, with the
goal of conversion from
a mechanical to a xeno-
graft aortic valve prosthesis.
We describe an easily reproducible technique that aims at
minimizing the degree of complexity of such reintervention while
still achieving the goal of freedom from anticoagulation.
Clinical Summary
A 38-year-old man with a history of Marfan syndrome and intra-
venous drug abuse presented to our institution in 1999 with symp-
tomatic aneurysmal dilation of the aortic root and aortic regurgi-
tation and underwent aortic root replacement with a 27-mm
composite mechanical valved prosthesis (St Jude Medical, St Paul,
Minn). Despite enrollment in a drug rehabilitation program, the
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Figure 2. A, Transesophageal 2-chamber view. AML, Anterior
mitral leaflet; LAA, left atrial appendage; LV, left ventricle. B,
Transesophageal-transgastric long-axis view. PM, Papillary mus-
cle; LA, left atrium; AV, aortic valve.
Drs Vricella and Cameron (left to right)
Brief Communications
The Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 2 565
